Results 1 to 10 of about 376,311 (300)

A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final report [PDF]

Hepatology, 1981
W. Szmuness, Cladd E. Stevens, Edith Zang, Edward J. Harley, Aaron Kellner   +4 more
openalex   +2 more sources

Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose

Hepatology, 2022
The duration of protection from hepatitis B vaccination in children and adults is not known. In 1981, we used three doses of plasma‐derived hepatitis B vaccine to immunize a cohort of 1578 Alaska Native adults and children from 15 Alaska communities who ...
M. Bruce, Dana Bruden, D. Hurlburt, J. Morris, Sara S. Bressler, G. Thompson, Danielle Lecy, K. Rudolph, L. Bulkow, T. Hennessy, Brenna C. Simons, Mark K. Weng, Noele P. Nelson, B. McMahon   +13 more
semanticscholar   +1 more source

Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine

JAMA Network Open, 2021
Key Points Question What is the immunogenicity and safety of a 3-antigen hepatitis B virus (HBV) vs a single-antigen HBV vaccine among young adults? Findings This randomized clinical trial of 2838 participants found that the 3-antigen HBV vaccine was ...
T. Vesikari, A. Finn, P. van Damme, I. Leroux-Roels, G. Leroux-Roels, N. Segall, Azhar Toma, G. Vallieres, R. Aronson, D. Reich, S. Arora, P. Ruane, Clancy L Cone, M. Manns, C. Cosgrove, S. Faust, M. Ramasamy, Nathalie Machluf, J. Spaans, B. Yassin-Rajkumar, D. Anderson, V. Popovic, F. Diaz-Mitoma   +22 more
semanticscholar   +1 more source

Hepatitis B Vaccines [PDF]

The Journal of Infectious Diseases, 2017
Abstract Hepatitis B is caused by the hepatitis B virus (HBV), which infects the liver and may lead to chronic liver disease, including cirrhosis and hepatocellular carcinoma. HBV represents a worldwide public health problem, causing major morbidity and mortality.
Pattyn, Jade, Hendrickx, Greet, Vorsters, Alex, van Damme, Pierre   +3 more
openaire   +4 more sources

Hepatitis B vaccine development and implementation

Human Vaccines & Immunotherapeutics, 2020
Vaccination against hepatitis B is the most effective strategy to control HBV infection. The first licensed hepatitis B vaccine was developed by the purification of hepatitis B surface antigen (HBsAg) from plasma of asymptomatic HBsAg carriers. Then, the
Hong Zhao, Xiaoying Zhou, Yihua Zhou
semanticscholar   +1 more source

Association of Number of Doses With Hepatitis B Vaccine Series Completion in US Adults

JAMA Network Open, 2020
Key Points Question Is completion of an adult hepatitis B virus vaccine series higher among recipients of a 2-dose vaccine compared with recipients of a 3-dose vaccine?
K. Bruxvoort, J. Slezak, Runxin Huang, B. Ackerson, L. Sy, L. Qian, K. Reynolds, W. Towner, Z. Solano, C. Mercado, R. Hyer, R. Janssen, S. Jacobsen   +12 more
semanticscholar   +1 more source

Hepatitis B vaccine knowledge and self-reported vaccination status among healthcare workers in a conflict region in northeastern Nigeria

Therapeutic Advances in Vaccines and Immunotherapy, 2020
Background Hepatitis B virus (HBV) infection is highly endemic in Nigeria. The primary objective of this study is to describe the knowledge, self-reported vaccination status, and intention of healthcare workers to receive hepatitis B vaccine at a ...
F. Dayyab, G. Iliyasu, B. Ahmad, A. T. Bako, S. Ngamariju, A. Habib   +5 more
semanticscholar   +1 more source

Hepatitis B vaccination [PDF]

BMJ, 2007
Hepatitis B virus is a substantial threat to global health, with 360 million people chronically infected and more than 500 000 deaths each year from fulminant hepatitis, cirrhosis, and liver cancer.1 2 After a call by the World Health Organization for the global introduction of vaccine prevention programmes by 1997,3 82% of countries in the world had ...
openaire   +5 more sources

Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant

MMWR. Morbidity and mortality weekly report, 2018
Hepatitis B (HepB) vaccination is the primary means of preventing infections and complications caused by hepatitis B virus (HBV). On February 21, 2018, the Advisory Committee on Immunization Practices (ACIP) recommended Heplisav-B (HepB-CpG), a yeast ...
S. Schillie, A. Harris, R. Link-Gelles, J. Romero, J. Ward, Noele P. Nelson   +5 more
semanticscholar   +1 more source

Hepatitis B Vaccine and Immunoglobulin: Key Concepts

Journal of Clinical and Translational Hepatology, 2019
Hepatitis B virus (HBV) immunization is safe and has been accepted worldwide as a routine practice. The target of such vaccination is to induce the immune response in the host, resulting in the prevention of replication of HBV.
S. Das, K. Ramakrishnan, S. Behera, Mahalakshmi Ganesapandian, A. S. Xavier, S. Selvarajan   +5 more
semanticscholar   +1 more source